Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

Completed · Phase 1

Conditions studied: HIV Infections

In brief

The purpose of this clinical research study is to assess the effect of Atazanavir 400 mg QD and Atazanavir/Ritonavir 300/100 mg QD at steady state on the single dose pharmacokinetics of RGZ in healthy subjects.

Key facts

Study ID

NCT00362726

Run by

Bristol-Myers Squibb

People needed

14

Starts

2006-09-01

Expected to finish

2006-11-01

Last updated by the study team

2011-04-08

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female subjects between the ages 18 to 50 years old with a BMI 18 to 32 kg/m2

Where it is running

• Local Institution — Hamilton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.